Business Description

Description
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -16.67
12-1 Month Momentum % -96.97

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -31.85

GF Value Rank

Name Current Vs Industry Vs History

Financials

STU:VIU1's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

VIVUS Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 65.887
EPS (TTM) (€) -2.432
Beta 0
Volatility % 41.16
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % -96.97
52-Week Range (€) 0.0095 - 4
Shares Outstanding (Mil) 17.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VIVUS Inc Filings

Filing Date Document Date Form
No Filing Data

VIVUS Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

VIVUS Inc Frequently Asked Questions

What is VIVUS Inc(STU:VIU1)'s stock price today?
The current price of STU:VIU1 is €0.06. The 52 week high of STU:VIU1 is €4.00 and 52 week low is €0.01.
When is next earnings date of VIVUS Inc(STU:VIU1)?
The next earnings date of VIVUS Inc(STU:VIU1) is .
Does VIVUS Inc(STU:VIU1) pay dividends? If so, how much?
VIVUS Inc(STU:VIU1) does not pay dividend.

Press Release

Subject Date
No Press Release